title: The importance of doing trials right while doing the right trials.
abstract: Effort is being expended in investigating efficiency measures (i.e., doing trials right) through achievement of accrual and endpoint goals for clinical trials. It is time to assess the impact of such trials on meeting the critical needs of cancer patients by establishing effectiveness measures (i.e., doing the right trials).
authors.affiliation: Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon 97239-3098, USA. dilts@ohsu.edu
authors.forename: David M
authors.initials: DM
authors.lastname: Dilts
authors.forename: Steven K
authors.initials: SK
authors.lastname: Cheng
mesh_terms: D017326:Clinical Trials, Phase III as Topic / Q000379:methods* / Q000706:statistics & numerical data*; D006801:Humans; D009369:Neoplasms / Q000628:therapy*; D012107:Research Design / Q000706:statistics & numerical data*
references.citation: J Clin Oncol. 2006 Oct 1;24(28):4545-52
references.pmid: 17008693
references.citation: Clin Cancer Res. 2010 Nov 15;16(22):5557-63
references.pmid: 21062929
references.citation: J Clin Oncol. 2011 Aug 10;29(23):3133-9
references.pmid: 21747079
references.citation: Oncologist. 2008 Sep;13(9):925-9
references.pmid: 18794216
references.citation: J Clin Oncol. 2010 Dec 10;28(35):5197-201
references.pmid: 21060029
references.citation: J Natl Cancer Inst. 2010 Sep 8;102(17):1371
references.pmid: 20682918
references.citation: Clin Cancer Res. 2012 Jan 1;18(1):256-62
references.pmid: 21976533